A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

NCT03683186 · clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

United Therapeutics